The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gorczynski, L.
Right arrow Articles by Gorczynski, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gorczynski, L.
Right arrow Articles by Gorczynski, R. M.
The Journal of Immunology, 1999, 162: 774-781.
Copyright © 1999 by The American Association of Immunologists

Evidence That an OX-2-Positive Cell Can Inhibit the Stimulation of Type 1 Cytokine Production by Bone Marrow-Derived B7-1 (and B7-2)-Positive Dendritic Cells1

Laura Gorczynski, Z. Chen, J. Hu, Y. Kai, J. Lei, V. Ramakrishna and R. M. Gorczynski2

Transplant Research Division, Toronto Hospital, Toronto, Ontario, Canada

We reported that hepatic mononuclear, nonparenchymal cells (NPC) can inhibit the immune response seen when allogeneic C57BL/6 dendritic cells (DC) are incubated with C3H spleen responder cells. Cells derived from these cultures transfer increased survival of C57BL/6 renal allografts in C3H mice. We also found that increased expression of OX-2 on DC was associated with inhibition of cytokine production and renal allograft rejection. We explored whether inhibition by hepatic NPC was a function of OX-2 expression by these cells. Fresh C57BL/6 spleen-derived DC were cultured with C3H spleen responder cells and other putative coregulatory cells. The latter were derived from fresh C3H or C57BL/6 liver NPC, or from C3H or C57BL/6 mice treated for 10 days by i.v. infusion of human Flt3 ligand. Different populations of murine bone marrow-derived DC from cultures of bone marrow with IL-4 plus granulocyte-macrophage-CSF were also used as a source of putative regulator cells. Supernatants of all stimulated cultures were examined for functional expression of different cytokines (IL-2, IL-4, IFN-{gamma}, and TGFß). We found that fresh C57BL/6 splenic DC induced IL-2, not IL-4, production. Cells from the sources indicated inhibited IL-2 and IFN-{gamma} production and promoted IL-4 and TGFß production. Inhibition was associated with increased expression of OX-2 on these cells, as defined by semiquantitative PCR and FACS analysis. By size fractionation, cells expressing OX-2 were a subpopulation of NLDC145+ cells. Our data imply a role for cells expressing OX-2 in the regulation of induction of cytokine production by conventional allostimulatory DC.




This article has been cited by other articles:


Home page
J. Immunol.Home page
R. Gorczynski, I. Khatri, L. Lee, and I. Boudakov
An Interaction between CD200 and Monoclonal Antibody Agonists to CD200R2 in Development of Dendritic Cells That Preferentially Induce Populations of CD4+CD25+ T Regulatory Cells
J. Immunol., May 1, 2008; 180(9): 5946 - 5955.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Kretz-Rommel, F. Qin, N. Dakappagari, E. P. Ravey, J. McWhirter, D. Oltean, S. Frederickson, T. Maruyama, M. A. Wild, M.-J. Nolan, et al.
CD200 Expression on Tumor Cells Suppresses Antitumor Immunity: New Approaches to Cancer Immunotherapy
J. Immunol., May 1, 2007; 178(9): 5595 - 5605.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C. M. Cameron, J. W. Barrett, L. Liu, A. R. Lucas, and G. McFadden
Myxoma Virus M141R Expresses a Viral CD200 (vOX-2) That Is Responsible for Down-Regulation of Macrophage and T-Cell Activation In Vivo
J. Virol., May 15, 2005; 79(10): 6052 - 6067.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. D. Rosenblum, E. Olasz, J. E. Woodliff, B. D. Johnson, M. C. Konkol, K. A. Gerber, R. J. Orentas, G. Sandford, and R. L. Truitt
CD200 is a novel p53-target gene involved in apoptosis-associated immune tolerance
Blood, April 1, 2004; 103(7): 2691 - 2698.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
A H Lau and A W Thomson
Dendritic cells and immune regulation in the liver
Gut, February 1, 2003; 52(2): 307 - 314.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
Y.-H. Chung, R. E. Means, J.-K. Choi, B.-S. Lee, and J. U. Jung
Kaposi's Sarcoma-Associated Herpesvirus OX2 Glycoprotein Activates Myeloid-Lineage Cells To Induce Inflammatory Cytokine Production
J. Virol., April 16, 2002; 76(10): 4688 - 4698.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
D. A. Clark, J.-W. Ding, G. Yu, G. A. Levy, and R. M. Gorczynski
Fgl2 prothrombinase expression in mouse trophoblast and decidua triggers abortion but may be countered by OX-2
Mol. Hum. Reprod., February 1, 2001; 7(2): 185 - 194.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
A. D. Dick, C. Broderick, J. V. Forrester, and G. J. Wright
Distribution of OX2 Antigen and OX2 Receptor within Retina
Invest. Ophthalmol. Vis. Sci., January 1, 2001; 42(1): 170 - 176.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
R. M. Gorczynski, K. Yu, and D. Clark
Receptor Engagement on Cells Expressing a Ligand for the Tolerance-Inducing Molecule OX2 Induces an Immunoregulatory Population That Inhibits Alloreactivity In Vitro and In Vivo
J. Immunol., November 1, 2000; 165(9): 4854 - 4860.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. M. Gorczynski, Z. Chen, D. A. Clark, J. Hu, G. Yu, X. Li, W. Tsang, and S. Hadidi
Regulation of Gene Expression of Murine MD-1 Regulates Subsequent T Cell Activation and Cytokine Production
J. Immunol., August 15, 2000; 165(4): 1925 - 1932.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. M. Gorczynski, M. S. Cattral, Z. Chen, J. Hu, J. Lei, W.-P. Min, G. Yu, and J. Ni
An Immunoadhesin Incorporating the Molecule OX-2 Is a Potent Immunosuppressant That Prolongs Allo- and Xenograft Survival
J. Immunol., August 1, 1999; 163(3): 1654 - 1660.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.